Literature DB >> 28425621

p53-competent cells and p53-deficient cells display different susceptibility to oxygen functionalized graphene cytotoxicity and genotoxicity.

Dayton M Petibone1, Thikra Mustafa2,3, Shawn E Bourdo2, Andersen Lafont4, Wei Ding1, Alokita Karmakar4, Zeid A Nima2, Fumiya Watanabe2, Daniel Casciano2, Suzanne M Morris1, Vasily N Dobrovolsky1, Alexandru S Biris2.   

Abstract

Due to the distinctive physical, electrical, and chemical properties of graphene nanomaterials, numerous efforts pursuing graphene-based biomedical and industrial applications are underway. Oxidation of pristine graphene surfaces mitigates its otherwise hydrophobic characteristic thereby improving its biocompatibility and functionality. Yet, the potential widespread use of oxidized graphene derivatives raises concern about adverse impacts on human health. The p53 tumor suppressor protein maintains cellular and genetic stability after toxic exposures. Here, we show that p53 functional status correlates with oxygen functionalized graphene (f-G) cytotoxicity and genotoxicity in vitro. The f-G exposed p53-competent cells, but not p53-deficient cells, initiated G0 /G1 phase cell cycle arrest, suppressed reactive oxygen species, and entered apoptosis. There was p53-dependent f-G genotoxicity evident as increased structural chromosome damage, but not increased gene mutation or chromatin loss. In conclusion, the cytotoxic and genotoxic potential for f-G in exposed cells was dependent on the p53 functional status. These findings have broad implications for the safe and effective implementation of oxidized graphene derivatives into biomedical and industrial applications. Published 2017. This article has been contributed to by US Government employees and their work is in the public domain in the USA. Published 2017. This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Entities:  

Keywords:  TK6 and NH32 cell lines; apoptosis; cell cycle; chromosome damage; cytotoxicity; graphene; p53 tumor suppressor; reactive oxygen species

Mesh:

Substances:

Year:  2017        PMID: 28425621     DOI: 10.1002/jat.3472

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  4 in total

Review 1.  Toxicology data of graphene-family nanomaterials: an update.

Authors:  Feng Xiaoli; Chen Qiyue; Guo Weihong; Zhang Yaqing; Hu Chen; Wu Junrong; Shao Longquan
Journal:  Arch Toxicol       Date:  2020-04-02       Impact factor: 5.153

Review 2.  Genotoxicity of Graphene-Based Materials.

Authors:  Josefa Domenech; Adriana Rodríguez-Garraus; Adela López de Cerain; Amaya Azqueta; Julia Catalán
Journal:  Nanomaterials (Basel)       Date:  2022-05-24       Impact factor: 5.719

3.  Development and Application of TK6-derived Cells Expressing Human Cytochrome P450s for Genotoxicity Testing.

Authors:  Xilin Li; Si Chen; Xiaoqing Guo; Qiangen Wu; Ji-Eun Seo; Lei Guo; Mugimane G Manjanatha; Tong Zhou; Kristine L Witt; Nan Mei
Journal:  Toxicol Sci       Date:  2020-06-01       Impact factor: 4.849

4.  Graphene-based 2D constructs for enhanced fibroblast support.

Authors:  Ingrid Safina; Shawn E Bourdo; Karrer M Algazali; Ganesh Kannarpady; Fumiya Watanabe; Kieng Bao Vang; Alexandru S Biris
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.